Key facts
- It has raised $3.1M; the latest was Accelerator/Incubator in Jul 2025.
- Notable investors include Investissement Quebec, Front Row Ventures, Québec Tech, ACET, La base entrepreneuriale HEC Montréal — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for MISO Chip
- ·The full record, as it builds
Funding rounds
No funding rounds for MISO Chip are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About MISO Chip
Developer of a healthcare chip designed to detect human tumors. The company's platform offers a technology that has a new 3D cancer model, a microfluidic system, and a patented process to transfer drug-treated MDTs into paraffin, enabling the healthcare industry and cancer patients to decide the personalized therapeutic choices before the start of treatment and to participate in the effort to control the costs of health care systems.
- Sector
- Healthcare
- HQ
- Montreal, Canada
- Founded
- 2019
- Employees
- 8
- Website
- misochip.com/
- Ownership
- Privately Held (backing)
MISO Chip doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in MISO Chip shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on MISO Chip in its N-PORT filings yet. We sweep new filings monthly.